SCHEMBL25464167

SCHEMBL25464167

CC(C)(C(=O)NC1CC1)c1ccc(F)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CACNA1B Q00975 1/20 0.43
▸ TAS1R3 Q7RTX0 2/20 0.42
▸ TAS1R1 Q7RTX1 2/20 0.42
▸ TAS1R2 Q8TE23 2/20 0.42
▸ IDH2 P48735 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MCHR1 Q99705 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ AKR1C3 P42330 1/20 0.40
▸ AKR1C2 P52895 1/20 0.40
▸ DPP4 P27487 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25464213 0.83 NPC1 (0.49) NPC1RAB9ASMN1; SMN2CACNA1BHPGD
SCHEMBL25464169 0.80 LMNA (0.50) NPC1RAB9ASMN1; SMN2CACNA1BHPGD
SCHEMBL25460822 0.79 AKR1C3 (0.44) NPC1RAB9ACYP3A4CYP2C9AKR1C3
SCHEMBL25464108 0.78 TAS1R3 (0.47) NPC1RAB9ATAS1R3TAS1R1TAS1R2
SCHEMBL25463746 0.78 KCNN4 (0.45) NPC1RAB9AALDH1A1CYP3A4CYP2C9
SCHEMBL25464127 0.77 NPC1 (0.42) NPC1RAB9ASMN1; SMN2TAS1R3TAS1R1
SCHEMBL25464172 0.75 SSTR4 (0.44) NPC1RAB9ATAS1R3TAS1R1TAS1R2
SCHEMBL25464778 0.75 CNR1 (0.36) CACNA1BIDH2HPGDGAA
SCHEMBL25464788 0.75 TACR1 (0.42) TAS1R3TAS1R1TAS1R2IDH2MCHR1
SCHEMBL25464147 0.74 PDK1 (0.44) NPC1RAB9ASMN1; SMN2TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR NPC1 2460/4885RAB9A 658/4885SMN1; SMN2 1966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback